Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 23, 2010HaematologicaOpen Access

Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia

View Full Paper
Ask AI
Bookmark
Share

Authors

TBTrudy BuitenkampRMRon A. A. MathôtVHVálerie de Haas

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Buitenkamp et al. (2010) studied this question.

synapsesocial.com/papers/6a802d462cf87dafd7c8760ahttps://doi.org/10.3324/haematol.2009.019778
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study2007 · 167 citations
  2. 2Down syndrome, drug metabolism and chromosome 212004 · 120 citations